On January 9, Ambassador Wang Xuefeng of Denmark met with Lars Fruergaard Jørgensen, Global President and CEO of Novo Nordisk.

Ambassador Wang stated that cooperation in the biopharmaceutical and health industry between China and Denmark has been strong, with Novo Nordisk achieving fruitful results in its decades-long partnership with China, leading to mutual benefits. Last July, the 20th Central Committee of the Communist Party of China proposed major reform measures to improve the support mechanism for the development of innovative drugs and medical devices. The Central Economic Work Conference held in December signaled ongoing deepening of reforms and an expansion of high-level opening-up policies. Recently, the Chinese government issued guidance on the high-quality development of the pharmaceutical industry, creating vast opportunities for leading global pharmaceutical companies like Novo Nordisk to develop in China. Ambassador Wang expressed hope that Novo Nordisk would take the occasion of the 75th anniversary of diplomatic relations between China and Denmark this year to strengthen their confidence in cooperation, increase investment in China, and achieve better development.

Lars Fruergaard Jørgensen expressed that Novo Nordisk is confident in the economic outlook of China and its development there, and is willing to continue its commitment to the Chinese market to provide better drugs and quality services to patients.

https://finance.eastmoney.com/a/202501113294212249.html